Cerebral white matter rarefaction has both neurodegenerative and vascular causes and may primarily be a distal axonopathy

Authors

Thomas G. Beach, Banner Sun Health Research Institute, Sun City, Arizona, USA.
Lucia I. Sue, Banner Sun Health Research Institute, Sun City, Arizona, USA.
Sarah Scott, Banner Sun Health Research Institute, Sun City, Arizona, USA.
Anthony J. Intorcia, Banner Sun Health Research Institute, Sun City, Arizona, USA.
Jessica E. Walker, Banner Sun Health Research Institute, Sun City, Arizona, USA.
Richard A. Arce, Banner Sun Health Research Institute, Sun City, Arizona, USA.
Michael J. Glass, Banner Sun Health Research Institute, Sun City, Arizona, USA.
Claryssa I. Borja, Banner Sun Health Research Institute, Sun City, Arizona, USA.
Madison P. Cline, Banner Sun Health Research Institute, Sun City, Arizona, USA.
Spencer J. Hemmingsen, Banner Sun Health Research Institute, Sun City, Arizona, USA.
Sanaria Qiji, Banner Sun Health Research Institute, Sun City, Arizona, USA.
Analisa Stewart, Banner Sun Health Research Institute, Sun City, Arizona, USA.
Kayleigh N. Martinez, Banner Sun Health Research Institute, Sun City, Arizona, USA.
Addison Krupp, Banner Sun Health Research Institute, Sun City, Arizona, USA.
Rylee McHattie, Banner Sun Health Research Institute, Sun City, Arizona, USA.
Monica Mariner, Banner Sun Health Research Institute, Sun City, Arizona, USA.
Ileana Lorenzini, Banner Sun Health Research Institute, Sun City, Arizona, USA.
Angela Kuramoto, Banner Sun Health Research Institute, Sun City, Arizona, USA.
Kathy E. Long, Banner Sun Health Research Institute, Sun City, Arizona, USA.
Cécilia Tremblay, Banner Sun Health Research Institute, Sun City, Arizona, USA.
Richard J. Caselli, Department of Neurology, Mayo Clinic, Scottsdale, Arizona, USA.
Bryan K. Woodruff, Department of Neurology, Mayo Clinic, Scottsdale, Arizona, USA.
Steven Z. Rapscak, Banner Alzheimer's Institute, Tucson, Arizona, USA.
Christine M. Belden, Banner Sun Health Research Institute, Sun City, Arizona, USA.
Danielle Goldfarb, Banner Sun Health Research Institute, Sun City, Arizona, USA.
Parichita Choudhury, Banner Sun Health Research Institute, Sun City, Arizona, USA.
Erika D. Driver-Dunckley, Department of Neurology, Mayo Clinic, Scottsdale, Arizona, USA.
Shyamal H. Mehta, Department of Neurology, Mayo Clinic, Scottsdale, Arizona, USA.
Marwan N. Sabbagh, Barrow Neurological Institute, Phoenix, Arizona, USA.
Holly A. Shill, Barrow Neurological Institute, Phoenix, Arizona, USA.
Alireza Atri, Banner Sun Health Research Institute, Sun City, Arizona, USA.
Charles H. Adler, Department of Neurology, Mayo Clinic, Scottsdale, Arizona, USA.

Document Type

Article

Abstract

Cerebral white matter rarefaction (CWMR) was considered by Binswanger and Alzheimer to be due to cerebral arteriolosclerosis. Renewed attention came with CT and MR brain imaging, and neuropathological studies finding a high rate of CWMR in Alzheimer disease (AD). The relative contributions of cerebrovascular disease and AD to CWMR are still uncertain. In 1181 autopsies by the Arizona Study of Aging and Neurodegenerative Disorders (AZSAND), large-format brain sections were used to grade CWMR and determine its vascular and neurodegenerative correlates. Almost all neurodegenerative diseases had more severe CWMR than the normal control group. Multivariable logistic regression models indicated that Braak neurofibrillary stage was the strongest predictor of CWMR, with additional independently significant predictors including age, cortical and diencephalic lacunar and microinfarcts, body mass index, and female sex. It appears that while AD and cerebrovascular pathology may be additive in causing CWMR, both may be solely capable of this. The typical periventricular pattern suggests that CWMR is primarily a distal axonopathy caused by dysfunction of the cell bodies of long-association corticocortical projection neurons. A consequence of these findings is that CWMR should not be viewed simply as "small vessel disease" or as a pathognomonic indicator of vascular cognitive impairment or vascular dementia.

Medical Subject Headings

Female; Humans; White Matter (pathology); Brain (pathology); Cerebrovascular Disorders (complications, diagnostic imaging, pathology); Alzheimer Disease (diagnostic imaging, pathology); Dementia, Vascular (pathology)

Publication Date

5-25-2023

Publication Title

Journal of neuropathology and experimental neurology

E-ISSN

1554-6578

Volume

82

Issue

6

First Page

457

Last Page

466

PubMed ID

37071794

Digital Object Identifier (DOI)

10.1093/jnen/nlad026

Share

COinS